Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Press
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
St. Mary's Chamber
Elk County Sheriff
St. Mary's Area School District
Elk County Catholic School System
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Alnylam Pharmaceuticals
(NQ:
ALNY
)
118.82
USD
-0.52 (-0.44%)
Official Closing Price
/ Updated:
5:49 PM EST, Jan 17, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
860,300
Open
119.01
Bid (Size)
110.00 (4)
Ask (Size)
124.99 (3)
Prev. Close
119.34
Today's Range
116.16 - 119.46
52wk Range
65.81 - 125.72
Shares Outstanding
100,522,411
Dividend Yield
N/A
Performance
YTD
+2.77%
+2.77%
1 Month
+0.82%
+0.82%
3 Month
+36.95%
+36.95%
6 Month
+55.54%
+55.54%
1 Year
+42.95%
+42.95%
Top News
More News
New Study Indicates 'Helper' Cells May Kill Cancerous Tumors
January 16, 2020
FN Media Group Presents USA News Group Market Commentary
Read More
from
PR Newswire
New Study Indicates ‘Helper’ Cells May Kill Cancerous Tumors
January 16, 2020
category
Featured News
from
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
More News
Read More
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2019 Global Net Product Revenues and Provides Additional Commercial Updates
January 12, 2020
from
Business Wire News Releases
Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 (PH1)
January 10, 2020
from
Business Wire News Releases
Alnylam to Webcast Presentation at 38th Annual J.P. Morgan Healthcare Conference
January 06, 2020
from
Business Wire News Releases
Noteworthy Friday Option Activity: ALNY, EHTH, PBYI
January 17, 2020
category
Stocks
from
Market News Video
Analysts Expect BBH To Hit $157
January 02, 2020
category
ETFs
from
ETF Channel
XBI, ICPT, SGEN, ALNY: Large Inflows Detected at ETF
December 27, 2019
category
ETFs
from
ETF Channel
Why Alnylam Pharmaceuticals Rose 57.9% in 2019
January 09, 2020
category
ALNY
,
Market News
from
Motley Fool
These 2 Stocks Will Fall After the New Year
January 03, 2020
category
Market News
,
JNJ
,
DRNA
, and 2 more.
from
Motley Fool
USSG, IDNA: Big ETF Inflows
December 23, 2019
category
ETFs
from
ETF Channel
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
